Reported Feb 22, 2017 · Terminated
Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc…
Actavis Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Actavis Inc · 400 Interpace Pkwy · Parsippany, NJ · 07054-1120
Is this the product you have?
- Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4
- Lot codes and dates
Lot #: 31342013134202Exp. 06/30/173134319Exp. 05/31/173135246Exp. 07/31/1731352473136781Exp. 08/31/173136782Exp. 09/30/1731369033136904Exp.10/31/173138250Exp. 07/31/173138968Exp. 08/31/173140000Exp. 09/30/17
- Amount recalled
- 499320 units
Where it was sold
- Nationwide
Why it was recalled
Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Actavis Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.